Cebranopadol: novel dual opioid/NOP receptor agonist analgesic
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.12461
Abstract: Chronic pain presents a difficult clinical challenge because of the limited efficacy, the limiting adverse‐effect profile or the abuse potential of current analgesic options. Cebranopadol is a novel new agent in clinical trials that combines… read more here.
Keywords: opioid nop; dual opioid; novel dual; cebranopadol novel ... See more keywords